Benzinga | Aug 3, 2021 07:10AM EDT

Seres Therapeutics Q2 EPS $(0.53) Misses $(0.37) Estimate

Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.37) by 43.24 percent. This is a 89.29 percent decrease over losses of $(0.28) per share from the same period last year.